LINC00266-1

Across TCGA pan-cancer cohorts, LINC00266-1 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LINC00266-1 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher LINC00266-1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00266-1 expression acts as an unfavorable survival marker, although some lineages such as ACC and UCS show a favorable association.

MESO, THCA, and KIRP are the cancer types where LINC00266-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Median	All	0.285	0.472	.003	87	view →
THCA	OS	Quartile	All	0.842	0.978	<.001	75	view →
KIRP	DFS	Tertile	III,IV	0.105	0.531	<.001	66	view →
KICH	OS	Median	All	0.888	1.000	<.001	61	view →
CESC	DFS	Tertile	III,IV	0.509	0.831	<.001	44	view →
ACC	OS	Tertile	III,IV	1.000	0.621	.007	38	view →
UVM	DFS	Quartile	III,IV	0.271	0.696	.004	21	view →
TGCT	DFS	Quartile	II,III,IV	0.621	1.000	.014	14	view →
BRCA	DFS	Quartile	All	0.414	0.598	.004	12	view →
GBM	OS	Median	All	0.223	0.305	.038	9	view →
UCS	OS	Median	IV	0.693	0.262	.047	6	view →
READ	OS	Median	IV	1.000	0.550	.028	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

LINC00266-1–MESO (OS)

Open the MESO breakdown →